Table 3.
Males |
Females |
||||
---|---|---|---|---|---|
Treatment group | ED50 | N | Treatment group | ED50 | N |
Sham-D | 5.65 ± 0.60 | 9 | |||
Sham-P | 6.82 ± 1.26 | 7 | |||
Sham | 5.61 ± 0.88*,** | 8 | Sham-E | 10.46 ± 0.93*,*** | 10 |
GDX + 0 | 9.49 ± 0.93 | 11 | GDX + 0 | 6.43 ± 1.05 | 11 |
GDX + T (low) | 5.30 ± 0.64* | 8 | GDX + E2 (low) | 15.61 ± 1.26* | 11 |
GDX + T (high) | 5.34 ± 0.90* | 8 | GDX + E2 (high) | 10.07 ± 1.35 | 9 |
GDX + E2 | 10.35 ± 1.43 | 11 | GDX + E2 (low)/P4 | 13.10 ± 1.05* | 8 |
GDX + DHT | 10.91 ± 1.93 | 7 | GDX + E2 (high)/P4 | 11.60 ± 1.00* | 10 |
GDX + E2/DHT | 6.80 ± 0.89 | 10 | GDX + P4 | 6.31 ± 1.18 | 11 |
GDX + T | 14.03 ± 1.81* | 10 |
For treatment group abbreviations see Table 2.
Significantly different from GDX + 0 rats of the same sex, P ≤ 0.05, Dunnett's.
Significantly different from sham-E females, P ≤ 0.05, t-test
Significantly different from sham-D and sham-P female rats, P ≤ 0.05, Student–Newman–Keuls.